Understanding how current chemotherapeutic modalities induce apoptosis is c
ritical to designing better anticancer agents. This review is concerned wit
h how pharmacological agents induce tumor cell apoptosis in a cell cycle-de
pendant manner. Recent experiments demonstrate that expression of several a
poptotic regulatory proteins (such as Bcl-2, Bar, p53, and Survivin) are di
fferentially regulated according to the phases of the cell cycle. This cell
cycle-dependent regulation in turn contributes to increased drug sensitivi
ty in different phases of the cell cycle. It is therefore likely that the c
ell cycle-dependent expression of cell death proteins plays a role in regul
ating chemosensitivity and apoptotic commitment of human tumor cells.